Salty Mystery and Silent Storm: Neonatal Shock Revealing Pseudohypoaldosteronism: A Case Study

Authors

  • Neel Kanwal
  • Aakash Bhatti
  • Raveena Kumari
  • Rahul Kumar
  • Ifra Shaikh
  • Meeran Bai

Keywords:

Pseudohypoaldosteronism, Aldosterone Resistance, Neonate, Hyperkalemia, Hyponatremia, Salt-Wasting.

Abstract

Pseudohypoaldosteronism (PHA) is a rare but serious condition in neonates, often mimicking congenital adrenal hyperplasia (CAH). We present a case of a 16-day-old female neonate with a 10-day history of persistent vomiting, poor feeding, lethargy, and severe dehydration. Laboratory findings revealed hyponatremia, hyperkalemia, and metabolic acidosis. Initial suspicion of CAH prompted steroid therapy, but hormone profiles showed normal cortisol, Adrenocorticotropic hormone (ACTH), and 17-hydroxyprogesterone levels with markedly elevated renin and aldosterone levels, confirming PHA. The infant responded to fluid resuscitation, sodium supplementation, and potassium-binding therapy. This case highlights the importance of early differentiation between CAH and PHA to guide appropriate management and avoid unnecessary corticosteroid therapy.

References

1. Küçükali GK, Çetinkaya S, Tunç G, O?uz MM, Çelik N, Akka? KY et al. Clinical management in systemic type pseudohypoaldosteronism due to SCNN1B variant and literature review. Journal of clinical research in pediatric endocrinology. 2021; 13(4): 446.

2. Joshi K, Verma PK, Barman M. Systemic pseudohypoaldosteronism type 1 due to a novel mutation in SCNN1B gene: a case report. EJIFCC. 2022; 33(3): 268.

3. Attia NA, Marzouk YI. Pseudohypoaldosteronism in a neonate presenting as life?threatening hyperkalemia. Case Reports in Endocrinology. 2016; 2016(1): 6384697.

4. Tauber KA, Ermacor K, Listman J. Cardiac arrest in a newborn: A case of pseudohypoaldosteronism. Clin Case Reports. 2024; 12(2): e8265.

5. Fernandes NCB, Simensato DCU, Vizzotto LJH, de Argollo Haber RS, Jacob CGF, Sanches ASO et al. Pseudohipoaldosteronism Type 1: a case report supported by a literature review. Int J Nutrology. 2022; 15(3): 1-7.

6. Huneif MA, Alhazmy ZH, Shoomi AM, Alghofely MA, Heena H, Mushiba AM et al. A novel SCNN1A variation in a patient with autosomal-recessive pseudohypoaldosteronism type 1. J Clin Res Pediatr Endocrinol. 2022; 14(2): 244.

7. Amin N, Alvi N, Barth J, Field H, Finlay E, Tyerman K et al. Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinol Diabet Metab Case Rep. 2013; 2013: 130010. doi: 10.1530/EDM-13-0010. Epub 2013 Aug 30.

8. Shamanur SB, Prabhu KV, editors. Pseudohypoaldosteronism Type 1: a challenging diagnosis. Hormone Research in Paediatrics; 2017: Karger Allschwilerstrasse 10, Ch-4009 Basel, Switzerland.

9. Efthymiadou A, Gautschi I, van Bemmelen MX, Sertedaki A, Giannakopoulos A, Chrousos G et al. A mild and transient form of autosomal recessive pseudohypoaldosteronism type 1 caused by a novel mutation in the SCNN1A gene. Am J Physiol Endocrinol Metabol. 2023; 325(1): E1-E9.

Downloads

Published

01-09-2026

How to Cite

1.
Kanwal N, Bhatti A, Kumari R, Kumar R, Shaikh I, Meeran Bai. Salty Mystery and Silent Storm: Neonatal Shock Revealing Pseudohypoaldosteronism: A Case Study. J Liaq Uni Med Health Sci [Internet]. 2026 Sep. 1 [cited 2026 Sep. 2];25(04):346-8. Available from: http://121.52.154.205/index.php/jlumhs/article/view/1703

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.